Search
for
Sort by
Research 30 of 246
- CYP3A5 Polymorphism in Circulating Tumor Cells Confers an Increased Disease-Free Survival in DLBCL Patients Treated with R-CHOP
- A population pharmacokinetic model for individualized regimens of finasteride according to CYP3A5 genotype and liver function
- Pilot study: genetic distribution of AR, FGF5, SULT1A1 and CYP3A5 polymorphisms in male Mexican population with androgenetic alopecia.
- SAT340 Matters Of The HAART - Ritonavir Induced CYP3A4 Inhibition of Intranasal Fluticasone Leading To Cushing’s Syndrome
- Effect of a Benign Prostatic Hyperplasia (BPH) Xenobiotic - Croton membranaceus Müll.Arg. Root Extract on CYP1A2, CYP3A4, CYP2D6, and GSTM1 Drug Metabolizing Enzymes in Rat Model
- A Simple Decision Tree Suited for Identification of Early Oral Drug Candidates With Likely Pharmacokinetic Nonlinearity by Intestinal CYP3A Saturation
- Relationship of Early-Onset Baldness to Prostate Cancer in African-American Men
- Pharmacogenomic variation and chemotherapy-related toxicity profiles in pediatric patients with cancer in Tanzania: a cross-sectional study
- Cloning of a Functional Vitamin D Receptor from the Lamprey (Petromyzon marinus), an Ancient Vertebrate Lacking a Calcified Skeleton and Teeth
- Cushing's syndrome due to pharmacological interaction in a cystic fibrosis patient
- Drug safety evaluation of exemestane
- Cushing's syndrome due to pharmacological interaction in a cystic fibrosis patient
- Drug interactions between common dermatological medications and the oral anti-COVID-19 agents nirmatrelvir-ritonavir and molnupiravir
- Hormone receptor positive, HER2 negative metastatic breast cancer: Impact of CDK4/6 inhibitors on the current treatment paradigm
- Single nucleotide polymorphisms associated with elevated alanine aminotransferase in patients receiving asunaprevir plus daclatasvir combination therapy for chronic hepatitis C
- High-resolution mass spectrometric investigation of the phase I and II metabolites of finasteride in pig plasma, urine and bile
- Iatrogenic Cushing Syndrome and Secondary Adrenal Insufficiency Due to an Interaction Between Fluticasone and Ritonavir
- In vivo Pharmacokinetic Interactions of Finasteride and Identification of Novel Metabolites
- Identification of Metabolites for the Novel 5α‐Reductase Inhibitor Epristeride In Vitro and Its Potential Impact on Doping Testing
- Arecaceae
- Ferrous sulfate overdose
- Identification of human cytochrome P450 isozymes responsible for the in vitro oxidative metabolism of finasteride.
- Effects of mitotane treatment on human steroid metabolism: implications for patient management
- Docking-based workflow and ADME prediction of some compounds in Curcuma longa and Andrographis paniculata as polymerase PA-PB1 inhibitors of influenza A/H5N1 virus
- Teriflunomide in multiple sclerosis: an update
- Hair Loss Induced by Lopinavir-Ritonavir
- ラット精巣におけるビタミンD 代謝関連遺伝子の発現解析
- Lignans and Neolignans: Plant secondary metabolites as a reservoir of biologically active substances
- Differences in reproductive toxicology between alopecia drugs: an analysis on adverse events among female and male cases
- Issues in the Treatment of Epilepsy